SRRK
Scholar Rock Holding Corporation
NASDAQ · Healthcare · Biotechnology · US
$55.40
−0.97%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 144.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 26.59x
- Price / sales
- —
- Price / cash flow
- -22.78x
Enterprise value
- Enterprise value
- $6.5B
- EV / sales
- —
- EV / EBITDA
- -16.29x
- EV / EBIT
- -15.89x
- Market cap
- $6.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026